Proctocolitis: Clinical Trials

12 trials for Proctocolitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 terminated, 1 unknown, 1 withdrawn. 4 Phase 3, 2 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Terminated 2
Not applicable2Completed 1, Withdrawn 1
Phase 21Completed 1

Follow Proctocolitis: new trials by email Literature Review of Proctocolitis trials Research Report on Proctocolitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of FCI in the Detection of Proctosigmoiditis Caused by IBD
Field-cycling imaging (FCI) - Inflammatory Bowel Diseases, Proctosigmoiditis
Not applicableWithdrawnNHS Grampian2024-03-012024-05-14
Pilot Study for the Evaluation of Food Choices in Patients With Inflammatory Bowel Diseases (MICI2021)
Inflammatory Bowel Diseases
UnknownFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico452021-04-012021-10-15
Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified Colitis
GT3X Actigraph accelerometer. - Crohn's Enteritis, Crohn Disease
CompletedUniversity Hospital, Lille1002020-09-012026-04-21
Phenomics in Autoimmune and Inflammatory Diseases
1: AID groups, 2: Control groups - Healthy Volunteer, Rheumatoid Arthritis
CompletedAssistance Publique - Hôpitaux de Paris5372015-07-292023-08-08
Suspicion of Non IgE-mediated Cow's Milk Protein Allergy: Prevalence and Evolution
oral food challenge 1, oral food challenge 2 - Food Allergy in Infants, Proctocolitis
CompletedHôpital Armand Trousseau1002014-05-012020-12-03
The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis
Budesonide Foam - Proctitis, Proctosigmoiditis
Phase 3TerminatedBausch Health Americas, Inc.1142011-05-312019-08-14
Serologic Markers for Inflammatory Bowel Disease During Clinical Forms With Weak or Strong Evolution Capacities
Inflammatory Bowel Diseases
CompletedCentre Hospitalier Universitaire de Saint Etienne1942010-10-012011-11-03
Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis
PUR 0110 Rectal Enema 250 mg, PUR 0110 Rectal Enema 500 mg, PUR 0110 Rectal Enema 1000 mg - Left-Sided Ulcerative Colitis, Proctosigmoiditis
Phase 2CompletedPurGenesis Technologies Inc.342010-06-012018-05-01
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS.
Aloe vera gel - Aloe Vera Gel, Proctosigmoiditis, Remission, Trial, Ulcerative Colitis (UC)
Not applicableCompletedOspedale Sandro Pertini, Roma442010-03-102021-02-15
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
MAX-002, Placebo, Canasa® - Proctitis, Ulcerative
Phase 3TerminatedForest Laboratories1192009-11-302019-08-28
Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis
Budesonide, Placebo - Proctitis, Proctosigmoiditis
Phase 3CompletedBausch Health Americas, Inc.2812009-11-202019-08-14
Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis
Budesonide, Placebo - Proctitis, Proctosigmoiditis
Phase 3CompletedBausch Health Americas, Inc.2652009-11-172019-08-14

Narrower conditions

Inflammatory Bowel Diseases (8)  ·  Colitis, Ulcerative (5)  ·  Colonic Diseases (4)  ·  Crohn Disease (4)  ·  Gastrointestinal Diseases (4)  ·  Proctitis (4)  ·  Ulcer (4)  ·  Colitis (3)  ·  Digestive System Diseases (3)  ·  Gastroenteritis (3)  ·  Intestinal Diseases (3)  ·  Pathologic Processes (3)  ·  Rectal Diseases (3)  ·  Sigmoid Diseases (3)

Broader conditions

Colitis (9)  ·  Digestive System Diseases (9)  ·  Gastroenteritis (9)  ·  Intestinal Diseases (9)  ·  Rectal Diseases (9)  ·  Sigmoid Diseases (9)  ·  Colonic Diseases (8)  ·  Gastrointestinal Diseases (8)  ·  Proctitis (8)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Immune System Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Inflammatory Bowel Diseases (2)  ·  Skin and Connective Tissue Diseases (2)

Interventions

Budesonide (2)  ·  Aloe vera gel (1)  ·  Mesalamine (1)

Sponsors

Bausch Health Americas, Inc. (3)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1)  ·  Forest Laboratories (1)  ·  Hôpital Armand Trousseau (1)  ·  NHS Grampian (1)  ·  Ospedale Sandro Pertini, Roma (1)  ·  PurGenesis Technologies Inc. (1)  ·  University Hospital, Lille (1)

Countries

France (4)  ·  United States (4)  ·  Canada (1)  ·  Germany (1)  ·  Italy (1)  ·  Poland (1)  ·  United Kingdom (1)

Top investigators

Gillian Bain, Dr (1)  ·  Luca Elli, PhD (1)  ·  Theophilus J Gana, MD, PhD (1)

Results publications

PMID 25644096, PMID 27416045, PMID 22271464, PMID 27245762, PMID 30166293, PMID 32172690, PMID 32558265, PMID 3317057, PMID 36220315, PMID 38182406, PMID 41862407, PMID 6102236

NIH funding

2009 (1)